ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Sicong Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5950-8878; OpenAlex author ID A5034316277. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. Co-author DOI 10.1002/advs.202401845 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiaqi Yang · 1 shared paper, 2024 · strength 0.20
- Paper Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. DOI 10.1002/advs.202401845 ↗
Yifan Hong · 1 shared paper, 2024 · strength 0.20
- Paper Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. DOI 10.1002/advs.202401845 ↗
Tingbo Liang · 1 shared paper, 2024 · strength 0.20
- Paper Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. DOI 10.1002/advs.202401845 ↗
Xueli Bai · 1 shared paper, 2024 · strength 0.20
- Paper Inhibition of DEF-p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer. DOI 10.1002/advs.202401845 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.